This study identifies the novel role of YY2 in modulating BUB3‐mediated SAC activity and CIN, as well as YY2/BUB3‐mediated SAC activity and CIN levels role in determining tumor cell fates. The gene discussed is ADCY10; the disease is neoplasm.